Lastly, preclinical data suggest that the PI3K/AKT pathway is involved in the metabolic shift (from glycolysis to oxidative phosphorylation) that converts effector CD8+ T cells to memory T cells [94] and regulates the tumor associated macrophages’ (TAMs’) switch between immune stimulation and immune suppression [95]. This evidence concerns the gene CD8A and neoplasm.